We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFC
3801
DELISTED
Entegra Financial Corp.
ENFC
$2K ﹤0.01%
+81
New +$2.42K
OLBK
3802
DELISTED
Old Line Bancshares, Inc.
OLBK
$2K ﹤0.01%
+57
New +$1.55K
NVTR
3803
DELISTED
Nuvectra Corporation Common Stock
NVTR
$2K ﹤0.01%
1,330
-11,700
-90% -$22.9K
DHXM
3804
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
$2K ﹤0.01%
1,427
-4,173
-75% -$5.7K
CDOR
3805
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$2K ﹤0.01%
136
-2,866
-95% -$30.1K
CEMI
3806
DELISTED
Chembio diagnostics, Inc.
CEMI
$2K ﹤0.01%
+284
New +$1.69K
AAT
3807
American Assets Trust
AAT
$1.4B
$1K ﹤0.01%
+30
New +$1.41K
ABEO icon
3808
Abeona Therapeutics
ABEO
$413M
$1K ﹤0.01%
18
-331
-95% -$24.8K
AGEN
3809
Agenus
AGEN
$290M
$1K ﹤0.01%
20
+15
+300% +$803
AGX icon
3810
Argan
AGX
$8.37B
$1K ﹤0.01%
+34
New +$1.37K
AGYS icon
3811
Agilysys
AGYS
$3.06B
$1K ﹤0.01%
24
-2,012
-99% -$51.2K
AMPY icon
3812
Amplify Energy
AMPY
$166M
$1K ﹤0.01%
+200
New +$1.13K
AQMS icon
3813
Aqua Metals
AQMS
$10.2M
$1K ﹤0.01%
+4
New +$1.46K
ARTL icon
3814
Artelo Biosciences
ARTL
$2.51M
$1K ﹤0.01%
+1
New +$762
ASRV icon
3815
AmeriServ Financial
ASRV
$83.5M
$1K ﹤0.01%
+171
New +$708
AWRE icon
3816
Aware
AWRE
$27.7M
$1K ﹤0.01%
463
+33
+8% +$99
BCYC
3817
Bicycle Therapeutics
BCYC
$292M
$1K ﹤0.01%
92
+91
+9,100% +$782
BEEM icon
3818
Beam Global
BEEM
$25.3M
$1K ﹤0.01%
185
-1,281
-87% -$7.01K
BGFV
3819
DELISTED
Big 5 Sporting Goods
BGFV
$1K ﹤0.01%
682
-1,322
-66% -$2.62K
BLCN
3820
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$1K ﹤0.01%
+54
New +$1.26K
BMA icon
3821
Banco Macro
BMA
$5.35B
$1K ﹤0.01%
48
-52
-52% -$2.43K
BURL icon
3822
Burlington
BURL
$23.2B
$1K ﹤0.01%
4
-1,760
-100% -$324K
CAAS icon
3823
China Automotive Systems
CAAS
$133M
$1K ﹤0.01%
687
+6
+0.9% +$13
CAMT icon
3824
Camtek
CAMT
$7.25B
$1K ﹤0.01%
+152
New +$1.39K
CDTX
3825
DELISTED
Cidara Therapeutics
CDTX
$1K ﹤0.01%
34
+30
+750% +$1.01K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.